0001666071-23-000139.txt : 20231003 0001666071-23-000139.hdr.sgml : 20231003 20231003182748 ACCESSION NUMBER: 0001666071-23-000139 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231001 FILED AS OF DATE: 20231003 DATE AS OF CHANGE: 20231003 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lynton Nicholas Hollmeyer CENTRAL INDEX KEY: 0001941467 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38386 FILM NUMBER: 231305854 MAIL ADDRESS: STREET 1: C/O CARDLYTICS, INC. STREET 2: 675 PONCE DE LEON AVENUE NE, SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Cardlytics, Inc. CENTRAL INDEX KEY: 0001666071 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. [7370] IRS NUMBER: 263039436 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 BUSINESS PHONE: 888-798-5802 MAIL ADDRESS: STREET 1: 675 PONCE DE LEON AVENUE, NE STREET 2: SUITE 6000 CITY: ATLANTA STATE: GA ZIP: 30308 4 1 wk-form4_1696372056.xml FORM 4 X0508 4 2023-10-01 0 0001666071 Cardlytics, Inc. CDLX 0001941467 Lynton Nicholas Hollmeyer C/O CARDLYTICS, INC. 675 PONCE DE LEON AVENUE NE, SUITE 6000 ATLANTA GA 30308 0 1 0 0 Chief Legal & Privacy Officer 0 Common Stock 2023-10-01 4 M 0 25000 A 54486 D Common Stock 2023-10-01 4 M 0 415 A 54901 D Common Stock 2023-10-01 4 M 0 582 A 55483 D Common Stock 2023-10-01 4 M 0 1578 A 57061 D Common Stock 2023-10-02 4 S 0 6900 13.55 D 50161 D Common Stock 2023-10-02 4 S 0 3703 14.92 D 46458 D Common Stock 2023-10-02 4 S 0 2101 15.70 D 44357 D Common Stock 2023-10-02 4 S 0 47 16.35 D 44310 D Restricted Stock Unit 2023-10-01 4 M 0 25000 0 D Common Stock 25000 50000 D Restricted Stock Unit 2023-10-01 4 M 0 415 0 D Common Stock 415 0 D Restricted Stock Unit 2023-10-01 4 M 0 582 0 D Common Stock 582 5812 D Restricted Stock Unit 2023-10-01 4 M 0 1578 0 D Common Stock 1578 17358 D Each restricted stock unit ("RSU") represents a contingent right to receive one share of common stock of the Issuer. Shares sold to satisfy withholding tax obligations upon the delivery of shares of common stock for RSUs that vested on October 1, 2023. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $13.21 to $14.20, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (3), (4) and (5) to this Form 4. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $14.27 to $15.265, inclusive. The price reported is a weighted average sales price. These shares were sold in multiple transactions at prices ranging from $15.275 to $16.23, inclusive. This RSU award was originally for 100,000 shares. 25% of the RSUs award vested on each of July 1, 2023 and October 1, 2023. An additional 25% of the RSU award shall vest on each of January 1, 2024 and April 1, 2024, subject to the Reporting Person's continuous service with the Issuer through each applicable vesting date. This RSU award was originally for 830 shares. Fifty percent (50%) of the shares under this award vested on October 1, 2022, and fifty percent (50%) of this award vested on October 1, 2023. This RSU award was originally for 9,299 shares. Twenty-five percent (25%) of the shares under this award vested on April 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. This RSU award was originally for 38,222 shares. Twenty-five percent (25%) of the shares under this award vested on July 1, 2023, with the remaining 75% vesting quarterly over the subsequent three years in equal amounts thereafter provided the Reporting Person continuously provides service to the Issuer through the vesting date. /s/ Jason Minio, Attorney-in-Fact 2023-10-03